Chiome Bioscience Inc. (4583) Other
Market cap
¥7.3B
P/E ratio
Develops antibody drugs for cancer and other diseases using its ADLib® System technology, while providing antibody development services to pharmaceutical companies.
| 2011/03 | 2012/03 | 2013/03 | 2014/03 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | - | -6 | -10.8 | -6.7 | -16.7 | -8.3 | -6.5 | -21.8 | -9.4 | -15.2 | -5 | -8.7 |
| Return on equity (%) | - | - | - | - | - | |||||||||||
| Employees | 29 | 29 | 31 | 37 | 40 | 60 | 42 | 37 | 37 | 38 | 42 | 49 | 49 | 51 | 47 | 49 |